Gene · 440
Papers1,669
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 1,669
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Arginine depletion potentiates standard-of-care chemo-immunotherapy in preclinical models of high-risk neuroblastoma. | J Exp Clin Cancer Res | 2025 | 40813699 | PubTator, text mining | PubMed |
| CCT196969 inhibits TNBC by targeting the HDAC5/RXRA/ASNS axis to down-regulate asparagine synthesis. | J Exp Clin Cancer Res | 2025 | 40781327 | PubTator, text mining | PubMed |
| Asparagine synthetase modulates glutaminase inhibitor sensitivity through metabolic reprogramming and serves as a prognostic biomarker in hepatocellular carcinoma. | Redox Biol | 2025 | 40779838 | PubTator, text mining | PubMed |
| GPS2 confers l-asparaginase resistance in acute lymphoblastic leukemia cells through ATF4/ASNS axis. | Carcinogenesis | 2025 | 40693356 | PubTator, text mining | PubMed |
| Natural Lysine-Reactive Meroterpenoids, Stachybenzals A-C, as Covalent Asparagine Synthetase Inhibitors. | J Nat Prod | 2025 | 40635137 | PubTator, text mining | PubMed |
| Targeting glutamine metabolism as a potential target for cancer treatment. | J Exp Clin Cancer Res | 2025 | 40598593 | PubTator, text mining | PubMed |
| FAM50A drives breast cancer brain metastasis through interaction with C9ORF78 to enhance ʟ-asparagine production. | Sci Adv | 2025 | 40531994 | PubTator, text mining | PubMed |
| Application of a Multiomics Imaging Workflow to Explore Asparlas Treatment in Solid Tumors. | Anal Chem | 2025 | 40497651 | PubTator, text mining | PubMed |
| Inhibition of CCT5-mediated asparagine biosynthesis and anti-PD-L1 produce synergistic antitumor effects in colorectal cancer. | Acta Pharm Sin B | 2025 | 40487665 | PubTator, text mining | PubMed |
| Case Report: a novel homozygous ASNS variant in a Chinese female with severe microcephaly, encephalopathy and epilepsy. | Front Neurosci | 2025 | 40421135 | Swiss-Prot, curated | PubMed |
| Targeting the Exonic Circular OGT RNA/O-GlcNAc Transferase/Forkhead Box C1 Axis Inhibits Asparagine- and Alanine-Mediated Ferroptosis Repression in Neuroblastoma Progression. | Research (Wash D C) | 2025 | 40416363 | PubTator, text mining | PubMed |
| Modulation of the Product Upon the Reaction of CO2 With Dimethylamine Cluster: A Topological Analysis of the Reaction Mechanism. | J Comput Chem | 2025 | 40369853 | PubTator, text mining | PubMed |
| Cancer-Type-Specific DNA Methylation Is a Source of Vulnerability in Liver Cancer Cells. | Cancer Sci | 2025 | 40313132 | PubTator, text mining | PubMed |
| Identification of a novel signature derived from ferroptosis-related genes to predict prognosis, immune landscape and chemotherapeutic sensitivity in head and neck squamous cell carcinoma. | J Stomatol Oral Maxillofac Surg | 2025 | 40306361 | PubTator, text mining | PubMed |
| Computational Identification and Validation of Metabolic Cell Death-Related Prognostic Biomarkers for Personalized Treatment Strategies in Prostate Cancer. | Cell Biochem Biophys | 2025 | 40210782 | PubTator, text mining | PubMed |
| Identification of endoplasmic reticulum stress-related genes as prognostic markers in colon cancer. | Cancer Biol Ther | 2025 | 40169935 | PubTator, text mining | PubMed |
| The Expression of Ferroptosis-Related Genes in Hepatocellular Carcinoma and Their Relationships With Prognosis. | J Hepatocell Carcinoma | 2025 | 40130081 | PubTator, text mining | PubMed |
| Asparagine drives immune evasion in bladder cancer via RIG-I stability and type I IFN signaling. | J Clin Invest | 2025 | 39964752 | PubTator, text mining | PubMed |
| The High-Affinity IL-2 Receptor Affects White Matter Damage after Cerebral Ischemia by Regulating CD8 + T Lymphocyte Differentiation. | J Neuroimmune Pharmacol | 2025 | 39821696 | PubTator, text mining | PubMed |
| NEK8 promotes the progression of gastric cancer by reprogramming asparagine metabolism. | Mol Med | 2025 | 39762761 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/440/papers?page=4